| Title | Author(s) | Year | View Count |  | CD133 + liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling | Tang, KH; Ma, S; Lee, TK; Chan, YP; Kwan, PS; Tong, CM; Ng, IO; Man, K; To, KF; Lai, PB; Lo, CM; Guan, XY; Chan, KW | 2012 | 183 |
 | Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis | Feng, H; Cheng, ASL; Tsang, DP; Li, MS; Go, MY; Cheung, YS; Zhao, GJ; Ng, SS; Lin, MC; Yu, J; Lai, PB; To, KF; Sung, JJY | 2011 | 257 |
| Reduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosis | Cheng, IK; Ching, AK; Chan, TC; Chan, AW; Wong, CK; Choy, KW; Man, K; Lai, PB; Wong, N | 2010 | 376 |
| Laparoendoscopic single-site surgery cholecystectomy using a novel retraction device | Teoh, AY; Wong, JS; Chiu, PW; Lai, PB; Ng, EK | 2010 | 118 |
| A multi-center phase II trial of bevacizumab (B) pre- and post-transarterial chemoembolization (TACE) treatment for patients with localized unresectable HCC: interim safety report | Poon, R; Yau, T; Chan, P; Tai, KS; Cheung, TT; Chan, A; Kwok, PC; Jin, K; Lee, KF; Lai, PB | 2010 | 105 |
|
